Table 1 Relationships between SNCG expression and clinicopathological characteristics in cervical cancer patients
From: Silencing of Synuclein-γ inhibits human cervical cancer through the AKT signaling pathway
Characteristics | SNCG expression (30) | P | |
|---|---|---|---|
Low (n) | High (n) | ||
Age | |||
< 50 | 6 | 7 | 0.532 |
≥ 50 | 6 | 11 | |
Tumor size (cm) | |||
≤ 4 | 10 | 9 | 0.021* |
> 4 | 3 | 8 | |
FIGO staging | |||
I-II | 9 | 8 | 0.016* |
III–IV | 3 | 10 | |
Histological grade | |||
Well differentiated | 5 | 6 | 0.577 |
Moderately to Poorly differentiated | 7 | 12 | |
Pelvic lymph node metastasis | |||
No | 11 | 10 | 0.021* |
Yes | 2 | 7 | |